The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

Patients with a recent first episode of schizophrenia who are treated with a long-acting injectable ...

Researchers from the University of Michigan Health System say that though antipsychotic medications ...

Individuals who self-identified as having schizophrenia judged improvement in their positive symptom...

The combination of alcohol and certain prescription medications has the potential to lead to adverse...

The duration of psychiatric illness and treatment for patients after first-episode schizophrenia spe...

Yesterday the Food and Drug Administration (FDA) released a warning stating that the use of ziprasid...

A study in the Journal of the American Medical Association (JAMA) reports on the first research to c...

Friday marked the inauguration of APA’s public involvement in the Choosing Wisely campaign—an initia...